<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/75067.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Drugs and Devices in the Clinical Management of Obesity Worldwide</title>
     <link>http://www.prweb.com/releases/2007/09/prweb552603.htm</link><description>   <![CDATA[ <P>As the growing worldwide problem of obesity becomes more evident, including its commensurate healthcare costs, there is a coinciding proliferation of the number and type of approaches to address the problem. (PRWeb Sep 12, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/09/prweb552603.htm">http://www.prweb.com/releases/2007/09/prweb552603.htm</a></P>]]>
                </description><pubDate>Wed, 12 Sep 2007 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/09/prweb552603.htm</guid>
        </item>
<item>
     <title>Obesity 2007: Worldwide Market for the Clinical Management of Obesity; Report from MedMarket Diligence, LLC</title>
     <link>http://www.prweb.com/releases/2007/07/prweb538225.htm</link><description>   <![CDATA[ <P>The clinical management of obesity represents a worldwide market -- encompassing devices, surgical procedures, drugs and other therapies -- that will surpass $5 billion by 2013.  MedMarket Diligence has closely tracked this market and will release its 2007 analysis of the worldwide market for products in the clinical management of obesity. (PRWeb Jul 9, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/07/prweb538225.htm">http://www.prweb.com/releases/2007/07/prweb538225.htm</a></P>]]>
                </description><pubDate>Mon, 09 Jul 2007 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2007/07/prweb538225.htm</guid>
        </item>
<item>
     <title>Products and Applications Proliferate in the Growing Market for Surgical Sealants, Glues and Wound Closure, According to New Report from MedMarket Diligence, LLC</title>
     <link>http://www.prweb.com/releases/2005/01/prweb200159.htm</link><description>   <![CDATA[ <P>Clinical experience with sealants, hemostatic agents, glues and a variety of novel wound closure technologies is coinciding with increased caseload in many different specialties including orthopedic, cardiovascular, dermal, surgical, neurology, and others.  These multiple opportunities are driving an $11 billion market by 2014. (PRWeb Jan 21, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/01/prweb200159.htm">http://www.prweb.com/releases/2005/01/prweb200159.htm</a></P>]]>
                </description><pubDate>Fri, 21 Jan 2005 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/01/prweb200159.htm</guid>
        </item>
<item>
     <title>Medical/Surgical Procedure Volumes, Reimbursement Levels and Top Volume Hospital Data Reveal Growth, Opportunity in Key Medtech Sectors</title>
     <link>http://www.prweb.com/releases/2004/10/prweb167507.htm</link><description>   <![CDATA[ <P>Data drawn from multiple sources, including Medicare, the National Center for Health Statistics, and the Healthcare Cost and Utilization Project, combined with insights from reimbursement consulting expert Medical Technology Partners and the medtech business focus of MedMarket Diligence, reveal trends and market opportunities in specific medical technology sectors.  Detailed reports are available on abdominal aortic aneurysm graft, gastric bypass, laparoscopic cholecystectomy, carotid endarterectomy, laminectomy, spine fusion and many others to guide decisions in the medtech sector. (PRWeb Oct 14, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/10/prweb167507.htm">http://www.prweb.com/releases/2004/10/prweb167507.htm</a></P>]]>
                </description><pubDate>Thu, 14 Oct 2004 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2004/10/prweb167507.htm</guid>
        </item>
<item>
     <title>Disc Arthroplasty Gaining Ground Among Spine Surgeons, Patients, According to MedMarkets</title>
     <link>http://www.prweb.com/releases/2004/08/prweb147087.htm</link><description>   <![CDATA[ <P>The limitations of spine fusion in addressing disc disease &#8212; a failure rate of 10% or higher, the creation of excessive stress on adjacent vertebrae, and the resulting persistent pain in an estimated 20% of patients &#8212; is causing fusion to be viewed more critically, especially in light of the clinical success of products in disc arthroplasty, according to the July 2004 issue of MedMarkets, published by MedMarket Diligence. (PRWeb Aug 6, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/08/prweb147087.htm">http://www.prweb.com/releases/2004/08/prweb147087.htm</a></P>]]>
                </description><pubDate>Fri, 06 Aug 2004 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2004/08/prweb147087.htm</guid>
        </item>
<item>
     <title>Spine Surgery Technologies and Products Improving Less Invasiveness and Quality of Outcomes, Yet Many Market Opportunities Remain, According to New MedMarket Diligence Report</title>
     <link>http://www.prweb.com/releases/2004/06/prweb134586.htm</link><description>   <![CDATA[ <P>A diverse array of diseases and disorders of the spine have been the target of spine surgery procedures and technologies that have achieved significant clinical success as well as success in medtech markets. The clinical practices and technology development continue to evolve and develop to improve outcomes cost. Spine conditions include congenital disorders, inflammatory and infectious diseases, degenerative diseases, traumatic conditions and mechanical disorders.  The MedMarket Diligence report details the current and future market worldwide for spine surgery technologies, providing a wealth of information on disease incidence, clinical practices and technology and market development. (PRWeb Jun 18, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/06/prweb134586.htm">http://www.prweb.com/releases/2004/06/prweb134586.htm</a></P>]]>
                </description><pubDate>Fri, 18 Jun 2004 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2004/06/prweb134586.htm</guid>
        </item>
<item>
     <title>Heart Failure is On the Rise, But is Under Siege by Multiple Therapeutic Alternatives and Approaches, According to New Report from MedMarket Diligence</title>
     <link>http://www.prweb.com/releases/2004/05/prweb123092.htm</link><description>   <![CDATA[ <P>Despite increases in the incidence and prevalence of heart failure, a wide range of therapeutic alternatives, from drugs to devices to surgical procedures, combined with aggressive monitoring and management strategies by clinicians and healthcare delivery systems are having tremendous impact on this disease.  A new report from MedMarket Diligence provides a detailed overview and analysis of heart failure management. (PRWeb May 3, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/05/prweb123092.htm">http://www.prweb.com/releases/2004/05/prweb123092.htm</a></P>]]>
                </description><pubDate>Mon, 03 May 2004 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2004/05/prweb123092.htm</guid>
        </item>
<item>
     <title>Peripheral Vascular and Non-Vascular Stenting Markets Continue Double-Digit Growth, According to Report from MedMarket Diligence.</title>
     <link>http://www.prweb.com/releases/2003/12/prweb94804.htm</link><description>   <![CDATA[ <P>Applications for stents, encompassing a variety endoluminal scaffolding devices, are steadily multiplying through their use in the management of many peripheral vascular and non-vascular diseases, and resulting in double-digit growth in manufacturer revenues. According to a report from MedMarket Diligence, this growth in peripheral stents evinces their potential to fit into the interventionalist's practice and capture caseload. (PRWeb Dec 18, 2003)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2003/12/prweb94804.htm">http://www.prweb.com/releases/2003/12/prweb94804.htm</a></P>]]>
                </description><pubDate>Thu, 18 Dec 2003 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2003/12/prweb94804.htm</guid>
        </item>
<item>
     <title>Targeted Therapeutics, Multiple Modalities Driving the $20 Billion U.S. Cancer Therapeutics Market, According to Report from MedMarket Diligence</title>
     <link>http://www.prweb.com/releases/2003/10/prweb86431.htm</link><description>   <![CDATA[ <P>New report issued by MedMarket Diligence on products, technologies and markets for cancer therapeutics. The report provides detailed incidence and prevalence data, trends in clinical practice and the competitors market shares and market outlook for a range of products in cancer therapeutics (PRWeb Oct 27, 2003)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2003/10/prweb86431.htm">http://www.prweb.com/releases/2003/10/prweb86431.htm</a></P>]]>
                </description><pubDate>Mon, 27 Oct 2003 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2003/10/prweb86431.htm</guid>
        </item>
<item>
     <title>Tissue Engineering and Transplantation Market Growth in Excess of 30% Annually, Many Companies in Pursuit, According to Report from MedMarket Diligence</title>
     <link>http://www.prweb.com/releases/2003/10/prweb86434.htm</link><description>   <![CDATA[ <P>The report examines the status of technologies, applications and markets for tissue engineering and transplantation products. The report reviews therapeutic technologies under various stages of development at several hundred companies, and profiles over 150. Products being developed address major causes of death and disease spanning applications in cardiovascular, neurological, orthopaedic, skin, organ and others. The report details the status of product development and assesses the current and forecast market for tissue engineering and transplantation products.  (PRWeb Oct 27, 2003)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2003/10/prweb86434.htm">http://www.prweb.com/releases/2003/10/prweb86434.htm</a></P>]]>
                </description><pubDate>Mon, 27 Oct 2003 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2003/10/prweb86434.htm</guid>
        </item>
</channel>
</rss>